227 related articles for article (PubMed ID: 25825242)
1. MRI evaluation of asymmetry of nigrostriatal damage in the early stage of early-onset Parkinson's disease.
Wang J; Yang QX; Sun X; Vesek J; Mosher Z; Vasavada M; Chu J; Kanekar S; Shivkumar V; Venkiteswaran K; Subramanian T
Parkinsonism Relat Disord; 2015 Jun; 21(6):590-6. PubMed ID: 25825242
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
[TBL] [Abstract][Full Text] [Related]
3. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
[TBL] [Abstract][Full Text] [Related]
4. Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease.
Prakash BD; Sitoh YY; Tan LC; Au WL
Parkinsonism Relat Disord; 2012 Nov; 18(9):1029-33. PubMed ID: 22705126
[TBL] [Abstract][Full Text] [Related]
5. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra.
Joshi N; Rolheiser TM; Fisk JD; McKelvey JR; Schoffer K; Phillips G; Armstrong M; Khan MN; Leslie RA; Rusak B; Robertson HA; Good KP
J Neurol; 2017 Jul; 264(7):1497-1505. PubMed ID: 28653210
[TBL] [Abstract][Full Text] [Related]
6. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.
Du G; Lewis MM; Styner M; Shaffer ML; Sen S; Yang QX; Huang X
Mov Disord; 2011 Aug; 26(9):1627-32. PubMed ID: 21618607
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
[TBL] [Abstract][Full Text] [Related]
8. High-resolution diffusion tensor-imaging indicates asymmetric microstructural disorganization within substantia nigra in early Parkinson's disease.
Knossalla F; Kohl Z; Winkler J; Schwab S; Schenk T; Engelhorn T; Doerfler A; Gölitz P
J Clin Neurosci; 2018 Apr; 50():199-202. PubMed ID: 29366621
[TBL] [Abstract][Full Text] [Related]
9. Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
Zhang Y; Wu IW; Tosun D; Foster E; Schuff N;
PLoS One; 2016; 11(10):e0165540. PubMed ID: 27798653
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
Geng DY; Li YX; Zee CS
Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
[TBL] [Abstract][Full Text] [Related]
11. Proton MR Spectroscopy for Monitoring Pathologic Changes in the Substantia Nigra and Globus Pallidus in Parkinson Disease.
Wu G; Shen YJ; Huang MH; Xing Z; Liu Y; Chen J
AJR Am J Roentgenol; 2016 Feb; 206(2):385-9. PubMed ID: 26797368
[TBL] [Abstract][Full Text] [Related]
12. Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited.
Langley J; Huddleston DE; Merritt M; Chen X; McMurray R; Silver M; Factor SA; Hu X
Hum Brain Mapp; 2016 Jul; 37(7):2547-56. PubMed ID: 27029026
[TBL] [Abstract][Full Text] [Related]
13. Diffusion basis spectrum imaging detects pathological alterations in substantia nigra and white matter tracts with early-stage Parkinson's disease.
Hu Z; Sun P; George A; Zeng X; Li M; Lin TH; Ye Z; Wei X; Jiang X; Song SK; Yang R
Eur Radiol; 2023 Dec; 33(12):9109-9119. PubMed ID: 37438642
[TBL] [Abstract][Full Text] [Related]
14. MRI diffusion in Parkinson's disease: using the technique's inherent directional information to study the olfactory bulb and substantia nigra.
Skorpil M; Söderlund V; Sundin A; Svenningsson P
J Parkinsons Dis; 2012; 2(2):171-80. PubMed ID: 23939442
[TBL] [Abstract][Full Text] [Related]
15. Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages.
Rossi ME; Ruottinen H; Saunamäki T; Elovaara I; Dastidar P
Acad Radiol; 2014 Jan; 21(1):64-71. PubMed ID: 24331266
[TBL] [Abstract][Full Text] [Related]
16. Case control study of diffusion tensor imaging in Parkinson's disease.
Chan LL; Rumpel H; Yap K; Lee E; Loo HV; Ho GL; Fook-Chong S; Yuen Y; Tan EK
J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1383-6. PubMed ID: 17615165
[TBL] [Abstract][Full Text] [Related]
17. Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease.
Zhang Y; Wu IW; Buckley S; Coffey CS; Foster E; Mendick S; Seibyl J; Schuff N
Mov Disord; 2015 Aug; 30(9):1229-36. PubMed ID: 25920732
[TBL] [Abstract][Full Text] [Related]
18. Striatal silent lacunar infarction is associated with changes to the substantia nigra in patients with early-stage Parkinson's disease: A diffusion kurtosis imaging study.
Zhang G; Zhang Y; Zhang C; Wang Y; Ma G; Nie K; Xie H; Liu J; Wang L
J Clin Neurosci; 2016 Nov; 33():138-141. PubMed ID: 27499120
[TBL] [Abstract][Full Text] [Related]
19. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
Schwarz ST; Rittman T; Gontu V; Morgan PS; Bajaj N; Auer DP
Mov Disord; 2011 Aug; 26(9):1633-8. PubMed ID: 21491489
[TBL] [Abstract][Full Text] [Related]
20. Parkinson disease: diagnostic utility of diffusion kurtosis imaging.
Wang JJ; Lin WY; Lu CS; Weng YH; Ng SH; Wang CH; Liu HL; Hsieh RH; Wan YL; Wai YY
Radiology; 2011 Oct; 261(1):210-7. PubMed ID: 21771952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
